Home › Funds › 5AM Venture Management, LLC › CLDX

5AM Venture Management, LLC position in CLDX

CELLDEX THERAPEUTICS INC NEW · Health Care

5AM Venture Management, LLC reported holding 497,270 shares of CLDX (CELLDEX THERAPEUTICS INC NEW) in its Q2 2026 13F filing — a position valued at US$18.5M, representing 6.43% of its reported portfolio and ranking #9 among its reported holdings. 5AM Venture Management, LLC has disclosed CLDX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)497.27K sh
Reported value held$18.50M
Portfolio Weight6.43%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How 5AM Venture Management, LLC's CLDX position evolved

5AM Venture Management, LLC first disclosed a stake in CLDX in Q3 2023 at 310,270 shares (US$8.5M). The position peaked in Q1 2024 at 497,270 shares, worth US$20.9M. Across 12 filings, 5AM Venture Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 497,270 shares valued at US$18.5M. Notable position changes include a 60% increase in Q4 2023 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 310.27K $8.54M New
Q4 2023 497.27K $19.72M Add
Q1 2024 497.27K $20.87M Hold
Q2 2024 497.27K $18.40M Hold
Q3 2024 497.27K $16.90M Hold
Q4 2024 497.27K $12.57M Hold
Q1 2025 497.27K $9.03M Hold
Q2 2025 497.27K $10.12M Hold
Q3 2025 497.27K $12.86M Hold
Q4 2025 497.27K $13.51M Hold
Q1 2026 497.27K $15.77M Hold
Q2 2026 497.27K $18.50M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLDX and 13F data

CLDX (CELLDEX THERAPEUTICS INC NEW) is a Health Care company. 44 other funds we track also report a position in CLDX — the largest reported positions include Kynam Capital Management, LP (US$198.1M), Deep Track Capital, LP (US$109.4M), Logos Global Management LP (US$78.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLDX

All CLDX fund holders →

FAQ

How long has 5AM Venture Management, LLC held CLDX?

5AM Venture Management, LLC has disclosed CLDX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is 5AM Venture Management, LLC's current position in CLDX?

As of Q2 2026, 5AM Venture Management, LLC holds 497.27K shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $18.50M, representing 6.43% of its reported portfolio and ranking #9.

Has 5AM Venture Management, LLC been buying or selling CLDX?

In the latest 13F filing (Q2 2026), 5AM Venture Management, LLC held unchanged its position in CLDX. The position peaked in Q1 2024 at 497.27K shares.

Which other funds hold CLDX?

Other major institutional holders of CLDX include Kynam Capital Management, LP, Deep Track Capital, LP, Logos Global Management LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.